In the BioHarmony Drug Report Database

"Preview" Icon

Oxaprozin

Daypro (oxaprozin) is a small molecule pharmaceutical. Oxaprozin was first approved as Daypro on 1992-10-29. It is used to treat juvenile arthritis, osteoarthritis, and rheumatoid arthritis in the USA. The pharmaceutical is active against prostaglandin G/H synthase 1 and prostaglandin G/H synthase 2. In addition, it is known to target bifunctional epoxide hydrolase 2.

 

Trade Name

 

Daypro
 

Common Name

 

oxaprozin
 

ChEMBL ID

 

CHEMBL1071
 

Indication

 

juvenile arthritis, osteoarthritis, rheumatoid arthritis
 

Drug Class

 

Image (chem structure or protein)

Oxaprozin structure rendering